Iptacopan
id:
iptacopan-204-11197507
title:
Iptacopan
text:
Iptacopan, sold under the brand name Fabhalta, is a medication used for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). It is a complement factor B inhibitor that was developed by Novartis. It is taken by mouth. Iptacopan was approved by the US Food and Drug Administration (FDA) for the treatment of adults with paroxysmal nocturnal hemoglobinuria in December 2023. The FDA considers it to be a first-in-class medication.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Iptacopan
date created:
2022-12-08T13:43:47Z
date modified:
2024-09-10T13:02:11Z
main entity:
{"identifier":"Q76803684","url":"https://www.wikidata.org/entity/Q76803684"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/bb/Iptacopan.svg","width":512,"height":481}
fields total:
13
integrity:
16